Georgy Egorov - 03 Jan 2022 Form 4 Insider Report for Vaccitech plc (VACC)

Role
Chief Financial Officer
Signature
/s/ William Enright, Attorney-in-Fact
Issuer symbol
VACC
Transactions as of
03 Jan 2022
Transactions value $
$0
Form type
4
Filing time
11 Feb 2022, 18:52:19 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VACC Share Option (Right to Buy) Award $0 +114K $0.00 114K 03 Jan 2022 Ordinary Shares 114K $11.12 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 This option shall vest and become exercisable in three equal annual installments, with the first installment vesting on January 3, 2023.